当前位置:首页 - 行情中心 - 艾迪药业(688488) - 财务分析 - 现金流量表

艾迪药业

(688488)

  

流通市值:68.59亿  总市值:68.59亿
流通股本:4.21亿   总股本:4.21亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金184,943,492.27697,381,262.66511,289,444.93337,709,529.25
  收到其他与经营活动有关的现金24,806,383.24166,817,841.86111,673,725.5171,758,605.39
  经营活动现金流入小计209,749,875.51864,199,104.52622,963,170.44409,468,134.64
  购买商品、接受劳务支付的现金49,322,261.59137,909,145.87103,839,174.8466,713,327.08
  支付给职工以及为职工支付的现金50,243,699.61142,434,709.29112,839,403.3178,264,424.29
  支付的各项税费29,778,225.23100,187,234.273,843,852.8337,611,921.78
  支付其他与经营活动有关的现金79,511,844.26466,036,514.39304,951,912.33202,430,065.28
  经营活动现金流出小计208,856,030.69846,567,603.75595,474,343.31385,019,738.43
  经营活动产生的现金流量净额893,844.8217,631,500.7727,488,827.1324,448,396.21
二、投资活动产生的现金流量:
  取得投资收益收到的现金382,220.951,510,922.151,221,649.87697,756.63
  处置固定资产、无形资产和其他长期资产收回的现金净额-4,084,860.43119,850-
  收到的其他与投资活动有关的现金80,000,000391,000,000314,400,000199,400,000
  投资活动现金流入小计80,382,220.95396,595,782.58315,741,499.87200,097,756.63
  购建固定资产、无形资产和其他长期资产支付的现金7,834,953.9847,934,622.8418,405,450.0416,599,571.61
  投资支付的现金-5,250,0001,750,0001,750,000
  取得子公司及其他营业单位支付的现金-5,040,0005,040,0005,040,000
  支付其他与投资活动有关的现金30,000,000365,000,000285,000,000185,000,000
  投资活动现金流出小计37,834,953.98423,224,622.84310,195,450.04208,389,571.61
  投资活动产生的现金流量净额42,547,266.97-26,628,840.265,546,049.83-8,291,814.98
三、筹资活动产生的现金流量:
  取得借款收到的现金328,380,000477,924,000371,924,000312,024,000
  筹资活动现金流入小计328,380,000477,924,000371,924,000312,024,000
  偿还债务支付的现金172,228,000404,656,000373,706,000266,012,000
  分配股利、利润或偿付利息支付的现金4,079,228.1320,871,234.5316,549,784.0412,726,499.59
  支付其他与筹资活动有关的现金70,452,665.142,358,778.61,896,009.491,833,676.09
  筹资活动现金流出小计246,759,893.27427,886,013.13392,151,793.53280,572,175.68
  筹资活动产生的现金流量净额81,620,106.7350,037,986.87-20,227,793.5331,451,824.32
四、汇率变动对现金及现金等价物的影响-71,035.3-101,064.52-47,703.57-8,346.65
五、现金及现金等价物净增加额124,990,183.2240,939,582.8612,759,379.8647,600,058.9
  加:期初现金及现金等价物余额365,199,115.63324,259,532.77324,259,532.77324,259,532.77
  期末现金及现金等价物余额490,189,298.85365,199,115.63337,018,912.63371,859,591.67
补充资料:
  净利润-8,083,067.42-26,489,470.65
  资产减值准备-17,011,257.89-2,896,425.23
  固定资产和投资性房地产折旧-33,489,540.73-16,952,447.15
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-33,489,540.73-16,952,447.15
  无形资产摊销-19,307,775.33-9,461,335.39
  长期待摊费用摊销-5,163,806.31-2,501,848.84
  处置固定资产、无形资产和其他长期资产的损失--81,281.88--99,170.37
  固定资产报废损失-169,273.7-137,770.56
  公允价值变动损失--18,221,056.17--14,218,294.32
  财务费用-15,620,774.14-8,096,590.56
  投资损失-736,346.86-568,771.59
  递延所得税-1,697,912.4-1,201,361.07
  其中:递延所得税资产减少-128,601.58--167,758.08
    递延所得税负债增加-1,569,310.82-1,369,119.15
  存货的减少--21,531,059.96--14,315,826.18
  经营性应收项目的减少--24,117,918.85--11,736,449.13
  经营性应付项目的增加--26,220,010.77--4,162,332.96
  其他-3,706,401.78--482,055.71
  现金的期末余额-365,199,115.63-371,859,591.67
  减:现金的期初余额-324,259,532.77-324,259,532.77
  现金及现金等价物的净增加额-40,939,582.86-47,600,058.9
公告日期2026-04-302026-03-312025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑